The Elgar Companion to Health EconomicsAndrew M. Jones Edward Elgar Publishing, 1 mrt 2006 - 584 pagina's This Companion is a timely addition. . . It contains 50 chapters, from 90 contributors around the world, on the topical and policy-relevant aspects of health economics. . . there is a balanced coverage of theoretical and empirical materials, and conceptua |
Inhoudsopgave
| 5 | |
2 The dynamics of health | 17 |
3 Health and work of older workers | 26 |
4 Using observational data to identify the causal eects of healthrelated behaviour | 36 |
5 Economics of public health interventions for children in developing countries | 46 |
6 Health behaviours among young people | 62 |
7 Economics of obesity | 72 |
8 Illicit drugs and drugrelated crime | 83 |
27 The role of economic incentives in improving the quality of mental health care | 286 |
28 Nursing home quality of care | 296 |
29 Direct to consumer advertising | 306 |
PART VI ASSESSING THE PERFORMANCE OF HEALTH CARE ORGANIZATIONS | 315 |
30 Concepts and challenges in measuring the performance of health care organizations | 317 |
31 The use of performance measures in health care systems | 326 |
32 Productivity analysis in health care | 335 |
PART VII MEASURING BENEFITS | 345 |
PART II HEALTH CARE FINANCE EXPENDITURE AND USE | 93 |
9 The value of health insurance | 95 |
10 Incentive and selection eects in health insurance | 104 |
11 Prescription drug insurance and reimbursement | 114 |
12 The economics of social health insurance | 126 |
13 Competition and health plan choice | 137 |
14 Empirical models of health care use | 147 |
15 The unocial health care economy in low and middleincome countries | 156 |
current challenges and future prospects of globalization | 164 |
PART III EQUITY IN HEALTH AND HEALTH CARE | 177 |
17 Decomposition of inequalities in health and health care | 179 |
18 Economic studies of equity in the consumption of health care | 193 |
19 Equity in health and health care systems in Asia | 205 |
PART IV ORGANIZATION OF HEALTH CARE MARKETS | 219 |
20 Hospital competition and patient choice in publicly funded health care | 221 |
21 Models of negotiation and bargaining in health care | 233 |
22 Contracts information and incentives in health care | 242 |
23 Contractingout health service provision in resource and informationpoor settings | 250 |
PART V PROVIDER REIMBURSEMENT INCENTIVES AND BEHAVIOUR | 259 |
24 The physician as the patients agent | 261 |
25 Capitation and incentives in primary care | 269 |
26 Optimal risk adjustment | 279 |
33 Conceptual foundations for health utility measurement | 347 |
34 The multiattribute utility approach to assessing healthrelated quality of life | 359 |
35 Methods for developing preferencebased measures of health | 371 |
36 The elicitation of distributional judgements in the context of economic evaluation | 382 |
37 Contingent valuation in health care | 392 |
38 Using discrete choice experiments in health economics | 405 |
39 Design of choice experiments in health economics | 415 |
PART VIII MEASURING COSTS AND STATISTICAL ISSUES | 427 |
40 Estimating costs for economic evaluation | 429 |
41 Dealing with skewed data on costs and expenditures | 439 |
42 Future costs in medical costeffectiveness analysis | 447 |
43 Selection bias in observational data | 455 |
PART IX ECONOMIC EVALUATION AND DECISION MAKING | 467 |
44 Decision rules for incremental costeffectiveness analysis | 469 |
principles and practice | 479 |
46 Decision rules in economic evaluation | 492 |
47 Statistical methods for costeectiveness analysis alongside clinical trials | 503 |
the value of information | 514 |
49 Perspectives on meanbased evaluation of health care | 526 |
50 Economic evaluation and decisionmakers | 537 |
| 547 | |
Overige edities - Alles bekijken
Veelvoorkomende woorden en zinsdelen
approach assessment attributes behaviour benefits cent chapter choice experiments choice sets clinical competition consumers contingent valuation contract cost-effectiveness analysis cost-effectiveness ratio countries covariates coverage DCEs decision decision-making demand developed distribution econometric economic evaluation effects efficiency empirical equity estimates evidence example function future costs Health Economics health insurance health plans health services health status hospital ICER illicit drug impact improve incentives income increase incremental incremental cost-effectiveness ratio individual inequality interventions issues Journal of Health literature measures Medicaid Medicare Medicine methods moral hazard mortality net-benefit Newhouse nursing home obesity observed optimal options outcomes parameters patients payer payment physicians population preferences problem programme providers public health QALY rates regression response Review risk adjustment sample sector selection bias social social health insurance standard gamble statistical studies theory tion treatment unobserved utility valuation weight World Health Organization zanamivir